Effect of Second-Generation Antipsychotics on Employment and Productivity in Individuals with Schizophrenia

@article{Percudani2004EffectOS,
  title={Effect of Second-Generation Antipsychotics on Employment and Productivity in Individuals with Schizophrenia},
  author={Maurlzlo Percudani and Corrado Barbui and Michele Tansella},
  journal={PharmacoEconomics},
  year={2004},
  volume={22},
  pages={701-718}
}
Schizophrenia is a serious mental illness that imposes a considerable burden not only on those who are ill, but also on their families, neighbours and the wider society. Costs associated with treating people with schizophrenia are those derived from the use of a wide range of services provided by public psychiatric facilities and/or by voluntary and private agencies. In addition, a large part of the economic impact of schizophrenia is related to the difficulties that patients encounter in… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 57 references

Efficacy and intercultural differences in family caregiving

  • S Leucht, G Pitschel-Walz, D Abraham
  • Schizophr Bull extrapyramidal side - effects of…
  • 2003

Burden on the generation antipsychotics and the evolving standard of care in families of patients with schizophrenia : results of the BI - Italy

  • D Taylor, D McConnell, +6 authors M Madianos
  • Pharmacopsychiatry
  • 2002

Comparing patterns and costs of schizophrenia care in five European countries : thehard to detect long - term differences . Secondly , data EPSILON Study

  • M Knapp
  • Acta Psychiatr Scand
  • 2002

Cost effectiveness of day Schizophr Bull

  • F Creed, P Mbaya, S Lancashire
  • 2002

Vocational rehabilitation for persons with chronic schizophrenia and schizoaffective disorder

  • JA Cook, L Razzano
  • Am J Psy - schizophrenia : recent research and…
  • 2002

Family response to mental JG , Limbird LE , Gilman AG , editors . The pharmacologic basisillness : developments since deinstitutionalisation

  • GA Fisher, PR Benson, RC Tessler
  • Res Com - of therapeutics
  • 2001